Strattera
Product Images NDC 68151-4484

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Strattera (NDC 68151-4484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 4484)

Strattera 10 mg capsule label showing active ingredient atomoxetine HCL, manufacturer Lilly, lot number C130895A, expiration date 10/14, and barcode with NDC 68151-4484. Label indicates prescription use only.*

FDA Label Image

Chemical Structure (Strattera1)

Chemical structure of the active ingredient in Strattera, depicted as a molecular diagram including aromatic rings, a chiral center, and a hydrochloride (HCl) moiety.*

FDA Label Image

Figure 1 (Strattera2)

Two line graphs comparing mean weight percentile and mean height percentile over 36 months of treatment in patients taking Strattera. The left graph shows weight percentile changes for 203 subjects, while the right graph shows height percentile changes for 155 subjects, both plotted with error bars across treatment duration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.